Clinical use of checkpoint inhibition in kidney cancer

ASCO Genitourinary Cancers Symposium

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)427-429
Number of pages3
JournalClinical Advances in Hematology and Oncology
Volume14
Issue number6
StatePublished - Jun 1 2016

Fingerprint

CD274 Antigen
Programmed Cell Death 1 Receptor
Antineoplastic Combined Chemotherapy Protocols
Molecular Targeted Therapy
Immunomodulation
Kidney Neoplasms
Protein Kinase Inhibitors
Antineoplastic Agents
Immunotherapy
Vascular Endothelial Growth Factor A
Signal Transduction
Monoclonal Antibodies

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Clinical use of checkpoint inhibition in kidney cancer. / ASCO Genitourinary Cancers Symposium.

In: Clinical Advances in Hematology and Oncology, Vol. 14, No. 6, 01.06.2016, p. 427-429.

Research output: Contribution to journalComment/debate

ASCO Genitourinary Cancers Symposium 2016, 'Clinical use of checkpoint inhibition in kidney cancer', Clinical Advances in Hematology and Oncology, vol. 14, no. 6, pp. 427-429.
ASCO Genitourinary Cancers Symposium. Clinical use of checkpoint inhibition in kidney cancer. Clinical Advances in Hematology and Oncology. 2016 Jun 1;14(6):427-429.
ASCO Genitourinary Cancers Symposium. / Clinical use of checkpoint inhibition in kidney cancer. In: Clinical Advances in Hematology and Oncology. 2016 ; Vol. 14, No. 6. pp. 427-429.
@article{8feaffb969714347be397a3df256c6f4,
title = "Clinical use of checkpoint inhibition in kidney cancer",
author = "{ASCO Genitourinary Cancers Symposium} and Hammers, {Hans J.}",
year = "2016",
month = "6",
day = "1",
language = "English (US)",
volume = "14",
pages = "427--429",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "6",

}

TY - JOUR

T1 - Clinical use of checkpoint inhibition in kidney cancer

AU - ASCO Genitourinary Cancers Symposium

AU - Hammers, Hans J.

PY - 2016/6/1

Y1 - 2016/6/1

UR - http://www.scopus.com/inward/record.url?scp=84975705431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975705431&partnerID=8YFLogxK

M3 - Comment/debate

VL - 14

SP - 427

EP - 429

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 6

ER -